ITGAM and lymphoma: We then administered a mixture of NK-sensitive lymphoma cells (RMA-s) and NK-non-sensitive lymphoma cells (RMA) in WT and CD11b−/− mice by intraperitoneal injection, the RMA cells being used as an internal control to normalize the remaining RMA-s cells.